By Dawood Fakhir ( October 22, 2025, 3:13 PM BST) -- Global biopharmaceutical company Ipsen said Wednesday that it will acquire a biotechnology company, ImCheck Therapeutics, from a consortium of French, European and U.S. investors for up to €1 billion ($1.16 billion) to boost the portfolio of its cancer treatments....

See Full Page